NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $724,892 | +0.6% | 7,116 | -0.3% | 0.03% | +3.8% |
Q2 2023 | $720,261 | +1.3% | 7,137 | -7.6% | 0.03% | +8.3% |
Q1 2023 | $710,852 | +21.6% | 7,726 | +19.9% | 0.02% | +14.3% |
Q4 2022 | $584,566 | -30.7% | 6,443 | -42.0% | 0.02% | -34.4% |
Q3 2022 | $844,000 | -9.7% | 11,103 | +0.3% | 0.03% | 0.0% |
Q2 2022 | $935,000 | +79.5% | 11,066 | +86.3% | 0.03% | +100.0% |
Q1 2022 | $521,000 | -22.1% | 5,940 | -22.4% | 0.02% | -15.8% |
Q4 2021 | $669,000 | -30.6% | 7,650 | -35.1% | 0.02% | -34.5% |
Q3 2021 | $964,000 | -8.4% | 11,782 | +2.2% | 0.03% | -6.5% |
Q2 2021 | $1,052,000 | +3.7% | 11,532 | -2.8% | 0.03% | -3.1% |
Q1 2021 | $1,014,000 | -2.6% | 11,863 | +7.6% | 0.03% | -8.6% |
Q4 2020 | $1,041,000 | +3.4% | 11,028 | -4.8% | 0.04% | -12.5% |
Q3 2020 | $1,007,000 | -1.9% | 11,580 | -1.5% | 0.04% | -11.1% |
Q2 2020 | $1,027,000 | +79.5% | 11,754 | +69.4% | 0.04% | +32.4% |
Q1 2020 | $572,000 | -52.0% | 6,937 | -44.9% | 0.03% | -32.0% |
Q4 2019 | $1,191,000 | +15.9% | 12,580 | +6.3% | 0.05% | +2.0% |
Q3 2019 | $1,028,000 | -6.4% | 11,832 | -1.6% | 0.05% | -14.0% |
Q2 2019 | $1,098,000 | +14.6% | 12,019 | +20.6% | 0.06% | +5.6% |
Q1 2019 | $958,000 | +6.2% | 9,963 | -5.2% | 0.05% | -18.2% |
Q4 2018 | $902,000 | +48.4% | 10,508 | +48.9% | 0.07% | +83.3% |
Q3 2018 | $608,000 | +11.6% | 7,059 | -2.2% | 0.04% | 0.0% |
Q2 2018 | $545,000 | -3.7% | 7,218 | +3.1% | 0.04% | -12.2% |
Q1 2018 | $566,000 | +1.4% | 7,000 | +5.4% | 0.04% | -4.7% |
Q4 2017 | $558,000 | +3.3% | 6,640 | +5.6% | 0.04% | -4.4% |
Q3 2017 | $540,000 | +7.4% | 6,290 | +4.4% | 0.04% | -4.3% |
Q2 2017 | $503,000 | +5.0% | 6,023 | -6.6% | 0.05% | +2.2% |
Q1 2017 | $479,000 | +7.4% | 6,447 | +5.4% | 0.05% | -6.1% |
Q4 2016 | $446,000 | -12.2% | 6,117 | -4.9% | 0.05% | -18.3% |
Q3 2016 | $508,000 | -5.9% | 6,431 | -1.7% | 0.06% | -14.3% |
Q2 2016 | $540,000 | +14.9% | 6,545 | +0.9% | 0.07% | +9.4% |
Q1 2016 | $470,000 | -28.8% | 6,486 | -15.4% | 0.06% | -30.4% |
Q4 2015 | $660,000 | -15.6% | 7,671 | -9.9% | 0.09% | -25.8% |
Q3 2015 | $782,000 | +4.5% | 8,512 | +12.0% | 0.12% | +20.4% |
Q2 2015 | $748,000 | +4.3% | 7,602 | +4.5% | 0.10% | +8.4% |
Q1 2015 | $717,000 | -28.7% | 7,276 | -32.9% | 0.10% | -28.6% |
Q4 2014 | $1,005,000 | – | 10,843 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |